Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 13/20 | 0.73 |
| ▸ | CYP11B2 | P19099 | 13/20 | 0.73 |
| ▸ | IDO1 | P14902 | 1/20 | 0.51 |
| ▸ | HPGDS | O60760 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.43 |
| ▸ | FNTA | P49354 | 1/20 | 0.43 |
| ▸ | FNTB | P49356 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8971686 | 0.90 | CYP11B1 (0.68) | CYP11B1CYP11B2IDO1HPGDSCYP2A6 | |
| SCHEMBL6774918 | 0.81 | CYP11B1 (0.82) | CYP11B1CYP11B2IDO1HPGDSP2RX7 | |
| SCHEMBL9570444 | 0.81 | CYP11B1 (0.68) | CYP11B1CYP11B2IDO1HPGDSP2RX7 | |
| SCHEMBL9121283 | 0.81 | CYP11B1 (0.68) | CYP11B1CYP11B2IDO1HPGDSP2RX7 | |
| SCHEMBL9092962 | 0.81 | CYP11B1 (0.72) | CYP11B1CYP11B2IDO1 | |
| Biphenyl SCHEMBL27333549 | 0.80 | CYP11B1 (0.66) | CYP11B1CYP11B2IDO1HPGDS | |
| SCHEMBL9123214 | 0.80 | CYP11B1 (0.66) | CYP11B1CYP11B2IDO1HPGDSP2RX7 | |
| Bromide SCHEMBL10583529 | 0.80 | CYP11B1 (0.66) | CYP11B1CYP11B2IDO1HPGDSP2RX7 | |
| Hydrochloric Acid SCHEMBL9122455 | 0.80 | CYP11B1 (0.66) | CYP11B1CYP11B2IDO1HPGDSP2RX7 | |
| Trifluoroacetic Acid SCHEMBL5880541 | 0.79 | CYP11B1 (0.58) | CYP11B1CYP11B2IDO1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102365254-B | Method for producing alcohol compound | SUMITOMO CHEMICAL CO | 2014-08-27 | — | — | CN | disclosed |
| CN-102365254-A | Method for producing alcohol compound | SUMITOMO CHEMICAL CO | 2012-02-29 | — | — | CN | disclosed |
| EP-2415741-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120010417-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010417-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | ADH1A, ADH1C, ADH5 | CYP11B1 28/4885CYP11B2 17/4885IDO1 3924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.